BalchC., BuzaidA.C., SoongS.J., AtkinsM.B., CascinelliN., CoitD.G., FlemingI.D., GershenwaldJ.E., HoughtonA., KirkwoodJ.M., McMastersK.M., MihmM.F., MortonD.L., ReintgenD.S., RossM.I., SoberA.J., ThompsonJ.A., ThompsonJ.F.: Final version of the AJCC staging system for cutaneous melanoma.J Clin Oncol, 2001, in press.
2.
BalchC.M., BuzaidA.C., AtkinsM.B., CascinelliN., CoitD.G., FlemingI.D., HoughtonA., KirkwoodJ.M., MihmM.F., MortonD.L., ReintgenD., RossM.I., SoberA., SoongS.J., ThompsonJ.A., ThompsonJ.F., GershenwaldJ.E., McMastersK.M.: A new American Joint Committee on Cancer staging system for cutaneous melanoma.Cancer, 88: 1484–1491, 2000.
3.
BalchC., SoongS.J., GershenwaldJ.E., ThompsonJ.F., ReintgenD.S., CascinelliN., UristM.M., McMastersK.M., RossM.I., KirkwoodJ.M., AtkinsM.B., ThompsonJ.A., CoitD.G., ByrdD., DesmondR., ZhangY., LiuP.Y., LymanG.H., and MorabitoA.: Prognostic factors analysis of 17, 600 melanoma patients. Validation of the new AJCC melanoma staging system.J Clin Oncol, 2001, in press.
4.
MortonD.L., WanekL., NizzeJ.A., ElashoffR.M., WongJ.H.: Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic.Ann Surg, 214: 491–499, (discussion 499-501) 1991.
5.
EssnerR., ConfortiA., KelleyM.C., WanekL., SternS., GlassE., MortonD.L.: Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma [see comments].Ann Surg Oncol, 6: 442–449, 1999.
6.
CascinelliN., BelliF., SantinamiM., VukF., TestoriA., RukaW., CavaliereR., MozzilloN., RossiC.R., MackieR.M., NiewegO., PaceM., KirovK.: Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience [In Process Citation].Ann Surg Oncol, 7: 469–474, 2000.
7.
MortonD.L., ThompsonJ.F., EssnerR., ElashoffR., SternS.L., NiewegO.E., RosesD.F., KarakousisC.P., MozzilloN., ReintgenD., WangH.J., GlassE.C., CochranA.J.: Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group.Ann Surg, 230: 453–463, (discussion 463-5), 1999.
8.
MortonD.L., ChanA.D.: Current status of intraoperative lymphatic mapping and sentinel lymphadenectomy for melanoma: is it standard of care?J Am Coll Surg, 189: 214–223, 1999.
9.
GershenwaldJ.E., TsengC.H., ThompsonW., MansfieldP.F., LeeJ.F., BouvetM., LeeJ.J., RossM.L.: Improved sentinel lymph node localization in patients with primary melanoma with the use of radiolabeled colloid.Surgery, 124: 203–210, 1998.
10.
GershenwaldJ.E., ThompsonW., MansfieldP.F., LeeJ.E., ColomeM.L., TsengC.H., LeeJ.J., BalchC.M., ReintgenD.S., RossM.L.: Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.J Clin Oncol, 17: 976–83, 1999.
11.
GershenwaldJ.E., PrietoV., Colome-GrimmerM.I., GiaccoG.G., SumnerW.E., MansfieldP.F., RossM.I., LeeJ.E.: The prognostic significance of microscopic tumor burden in 925 melanoma patients undergoing sentinel lymph node biopsy.Proc Am Soc Clin Oncol, 19: 551a, 2000.
12.
KirkwoodJ.M., IbrahimJ.G., SondakV.K., RichardsJ., FlahertyL.E., ErnstoffM.S., SmithT.J., RaoU., SteeleM., BlumR.H.: High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190.J Clin Oncol, 18: 2444–2458, 2000.
13.
BalchC.M., SoongS.J., MuradT.M., IngallsA.L., MaddoxW.A.: A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II).Ann Surg, 193: 377–388, 1981.
14.
BalchC.M., SoongS.J., MiltonG.W., ShawH.M., McGovernV.J., MuradT.M., McCarthyW.H., MaddoxW.A.: A comparison of prognostic factors and surgical results in 1, 786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia.Ann Surg, 196: 677–684, 1982.
BuzaidA.C., RossM.I., BalchC.M., SoongS., McCarthyW.H., TinocoL., MansfieldP., LeeJ.E., BedikianA., EtonO., PlagerC., PapadopoulosN., LeghaS.S., BenjaminR.S.: Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system [see comments].J Clin Oncol, 15: 1039–1051, 1997.
17.
CalabroA., SingletaryS.E., BalchC.M.: Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases.Arch Surg, 124: 1051–1055, 1989.
18.
MortonD.L., DavtyanD.G., WanekL.A., FoshagL.J., CochranA.J.: Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness.Cancer, 71: 3737–3743, 1993.
